Home/Filings/4/0001209191-24-003869
4//SEC Filing

Elliott Jeffrey Thomas 4

Accession 0001209191-24-003869

CIK 0001124140other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 7:38 PM ET

Size

10.3 KB

Accession

0001209191-24-003869

Insider Transaction Report

Form 4
Period: 2024-02-20
Elliott Jeffrey Thomas
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-203,1120 total
    Common Stock (3,112 underlying)
  • Sale

    Common Stock

    2024-02-21$61.50/sh1,493$91,8203,703 total
  • Exercise/Conversion

    Common Stock

    2024-02-20+3,1125,196 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,585
Footnotes (5)
  • [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
  • [F2]Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.
  • [F3]In addition to the shares of Common Stock reported on this Form 4, which total 5,288 shares, Mr. Elliott also holds, in the aggregate, an additional 140,678 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F5]Represents a restricted stock unit award granted on February 19, 2021 that vests in four equal annual installments from the grant date.

Issuer

EXACT SCIENCES CORP

CIK 0001124140

Entity typeother

Related Parties

1
  • filerCIK 0001689757

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:38 PM ET
Size
10.3 KB